Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | Oct 20, 2025 | Marram Investment Management | - | 3.0% | BPCP LN, SEI | Artificial Intelligence, Diagnostics, Growth Investing, healthcare, software | The fund reports steady progress driven by healthcare and technology holdings with durable pricing power and recurring revenues. It highlights selective AI opportunities in enterprise software and diagnostics but avoids speculative valuation extremes. Managers stress disciplined ownership of quality growth businesses with proven cash generation. | FOUR PYPL FOUR PYPL |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||